WASHINGTON - Eligible Medicare beneficiaries can now obtain certain anti-obesity medications for $50 a month under a new ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

By Mariam Sunny and Sneha S K July 1 (Reuters) - Millions of Americans are expected to gain coverage for GLP-1 drugs for ...

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...

The Centers for Medicare & Medicaid Services July 1 issued its calendar year 2027 proposed rule for the home health prospective payment system. The rule proposes a 2.4% update, which includes a 3.1% ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

BALTIMORE, Maryland, Nov. 15-- The U.S. Department of Health and Human Services' Centers for Medicare and Medicaid Services issued the following news release: The Centers for Medicare & Medicaid ...